Studies have concluded that CRP concentrations tend to be higher in patients with type 2 diabetes and that CRP can disrupt insulin homeostasis and increase the risk of disease by blocking the major cascade of downstream insulin signaling [25], and in vitro studies have also shown an association between serum CRP levels and β-cell dysfunction and insulin resistance[26]. This evidence concerns the gene INS and type 2 diabetes mellitus.